Citigroup
DXTR

Citigroup’s Dextera Surgical Inc. DXTR Stock Holding History

Citigroup’s Portfolio DXTR Stock Details DXTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,516
Closed – – 7756
2017
Q3 		$0 Sell
1,516
-100
-6% -$29 ﹤0.01% 7611
2017
Q2 		$0 Buy
1,616
+100
+7% +$51 ﹤0.01% 7628
2017
Q1 		$2K Sell
1,516
-636
-30% -$817 ﹤0.01% 7046
2016
Q4 		$2K Buy
2,152
+636
+42% +$958 ﹤0.01% 7089
2016
Q3 		$3K Sell
1,516
-100
-6% -$213 ﹤0.01% 6899
2016
Q2 		$3K Buy
+1,616
New +$3.31K ﹤0.01% 6900

Other funds holding DXTR

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Citigroup's DXTR Position: Q4 2017 in Review

Citigroup sold out of Dextera Surgical Inc. (DXTR) in Q4 2017, closing a stake of 1,516 shares.

Citigroup first reported a position in DXTR in Q2 2016 and held it in 6 quarters. The position peaked at $3K in Q3 2016. 3 funds tracked by Wall St. Rank hold DXTR as of Q4 2017.

  • Citigroup reported no remaining Dextera Surgical Inc. position as of Q4 2017 after selling out during the quarter.
  • Citigroup sold 1,516 Dextera Surgical Inc. shares in Q4 2017.
  • Citigroup first reported a position in Dextera Surgical Inc. in Q2 2016 and held it in 6 quarters.
  • Citigroup's Dextera Surgical Inc. position peaked at $3K in Q3 2016.
  • 3 funds tracked by Wall St. Rank held Dextera Surgical Inc. as of Q4 2017.

Based on Citigroup's 13F filing for Q4 2017, filed 12 Feb 2018.